Med Gen announced thatv Sales for the first fiscal quarter ended December were $958,000 for an increase of 136% from the year ago comparable quarter. For the 12 months ended December 2001, Sales were $2.8 million versus $1.4 million for the year earlier 1

Share Article

Sales for the Quarter ended December approximate $958,000 for an increase of 136% from year ago comparable quarter. TTM (trailing twelve month) Sales to 12/01: $2,829,000 versus $1,416,000 for the TTM to 12/00 for an increase of 100% for that period.



Date: January 14, 2002

Place: Boca Raton, Florida

Contact: Mr. Tom Heysek VP Investor Relations and Compliance (561) 750-1100

Med Gen to file First Quarter results showing 136% increase in Sales to $958,000

Trailing Twelve Months Sales: $2.8 million, an increase of 100% from 12/00

Paul S. Mitchell announced to investors that sales of Snorenz® continues to grow in popularity at all levels. Mr. Mitchell added "Although Snorenz® can now be found in approximately 25,000 retail stores nationwide, we expect to penetrate another 7,000 stores by our third fiscal quarter (June 2002)".

Paul B. Kravitz, Chairman and Chief Executive added that the Company is in the final stages of concluding an Investment Banking Agreement between a recognized Broker-Dealer and an Institutional Investor that will provide financial and stock market support to the Company. This will help the Company launch three new product lines and provide advertising to support and promote Snorenz® and its new Brands, Comfort Care™ (Magnets), 4in1™ (Topical Pain Relief) and GlucoFree™ (Diabetic Snore Relief Formula).

In an additional comment, Mr. Kravitz added that the management decision to offer stock in lieu of cash to compensate its officers, employees and consultants has proved sound, and has allowed the Company to use its cash to grow sales. In the future, as cash becomes less important, the Company will attempt to pay industry standard salaries to all employees. At this point, all management, employees and consultants have one singular interest, along with our shareholders and that is to increase shareholder value.

This Press Release contains or incorporates by reference “forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. (“MedGen™”). For this purpose, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes”, “suggests”, “anticipates”, “plans”, “expects”, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of MedGen™ operations that could differ materially from those indicated by such forward looking statements.

MedGen™ is a publicly traded Company, OTCBB “MGNI.OB”.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tom Heysek